Rhythm Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:0RY Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
14 Jun 24	Buy€24,979	Otto Buttula	Individual	600,000	€0.042
03 Jun 24	Buy€11,653	Otto Buttula	Individual	276,906	€0.042
27 May 24	Buy€22,923	Otto Buttula	Individual	546,273	€0.042

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0RY?
Owner Type	Number of Shares	Ownership Percentage
State or Government	2,500,000	0.882%
Institutions	13,634,749	4.81%
Private Companies	18,615,897	6.56%
Individual Insiders	78,634,758	27.7%
General Public	170,211,346	60%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.2%.

Top Shareholders

Top 25 shareholders own 39.97% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.8%	Otto Buttula	36,384,575	€1.7m	0%	no data
6.39%	Michelle Wing	18,117,500	€868.8k	0%	no data
4.15%	Fidelity International Ltd	11,777,709	€564.8k	6.13%	no data
2.84%	Loumea Investment Pty Ltd	8,052,520	€386.1k	0%	no data
1.49%	Rojo Nero Capital Pty Ltd	4,213,751	€202.1k	-2.54%	no data
1.41%	David Atkins	4,000,000	€191.8k	0%	no data
1.29%	Giokir Pty Ltd	3,661,470	€175.6k	0%	no data
1.17%	Soo Hsien	3,305,403	€158.5k	0%	no data
0.95%	Dc & Pc Holdings Pty Ltd	2,688,156	€128.9k	0%	no data
0.88%	Commonwealth Scientific and Industrial Research Organisation	2,500,000	€119.9k	0%	no data
0.87%	Natalie Patterson	2,477,083	€118.8k	0%	no data
0.65%	Ardroy Securities Pty Ltd, Asset Management Arm	1,857,040	€89.1k	5.51%	41.26%
0.59%	Trevor Lockett	1,678,300	€80.5k	0%	no data
0.55%	Anthony Hall	1,550,000	€74.3k	0%	no data
0.53%	A. Veliss	1,500,000	€71.9k	50%	no data
0.53%	Mark Rogers	1,500,000	€71.9k	50%	no data
0.38%	Louis Panaccio	1,079,000	€51.7k	0%	no data
0.37%	Julie Eddington	1,061,766	€50.9k	-82%	no data
0.37%	Daniel Eddington	1,061,766	€50.9k	-82%	no data
0.36%	Wei Feng	1,025,108	€49.2k	0%	no data
0.36%	Jie Liu	1,025,107	€49.2k	0%	no data
0.3%	Linda Lockett	839,150	€40.2k	0%	no data
0.24%	J. M. Molyneux	666,668	€32.0k	37.9%	no data
0.24%	J. E. Hutchison	666,666	€32.0k	37.9%	no data
0.24%	W. A. Hutchison	666,666	€32.0k	37.9%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 03:50
End of Day Share Price	2024/12/19 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rhythm Biosciences Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Stuart Roberts	Pitt Street Research Pty Ltd.